Stockreport

KalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for Sebetralstat

KalVista Pharmaceuticals, Inc.  (KALV) 
Last kalvista pharmaceuticals, inc. earnings: 3/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.kalvista.com
PDF – Full EAMS designation would allow treatment of patients with sebetralstat prior to receiving a Marketing Authorization from UK – CAMBRIDGE, Mass. & SALISBURY, Engla [Read more]